Literature DB >> 12709681

Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.

Shiun-Kwei Chiou1, Michael K Jones, Andrzej S Tarnawski.   

Abstract

Survivin is a protein that inhibits apoptosis and regulates cell division. Survivin contains a baculovirus inhibitor of apoptosis repeat (BIR) protein domain that classifies it as a member of the inhibitor of apoptosis protein (IAP) family. Survivin inhibits apoptosis, via its BIR domain, by either directly or indirectly interfering with the function of caspases. Survivin is also a chromosomal passenger protein that is required for cell division. Survivin is expressed in embryonic tissues as well as in the majority of human cancers, but is not expressed in most normal adult tissues. The cancer-specific expression of survivin, coupled with its importance in inhibiting cell death and in regulating cell division, makes it a useful diagnostic marker of cancer and a potential target for cancer treatment. Recently, there is emerging evidence that survivin is involved in tissue injury and its healing. Understanding the mechanism of survivin function can potentially allow for the development of therapeutic strategies for cancer and other diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709681

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  50 in total

1.  Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells.

Authors:  Nitin Nitin; Philip J Santangelo; Gloria Kim; Shuming Nie; Gang Bao
Journal:  Nucleic Acids Res       Date:  2004-04-14       Impact factor: 16.971

Review 2.  Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update.

Authors:  Jian-Ming Lü; Jacobo Nurko; Sarah M Weakley; Jun Jiang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Med Sci Monit       Date:  2010-05

3.  Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats.

Authors:  Erik A Johnson; Stanislav I Svetlov; Kevin K W Wang; Ronald L Hayes; Jose A Pineda
Journal:  Exp Brain Res       Date:  2005-10-29       Impact factor: 1.972

4.  Effect of siRNA targeting survivin gene on the biological behavior of hepatocellular carcinoma.

Authors:  Xin Lu; Qichang Zheng; Jun Xiong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

5.  Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity.

Authors:  Hai-Tao Guan; Xing-Huan Xue; Zhi-Jun Dai; Xi-Jing Wang; Ang Li; Zhao-Yin Qin
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

6.  Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.

Authors:  Ilya V Ulasov; Mathew A Tyler; Zeng B Zhu; Yu Han; Tong-Chuan He; Maciej S Lesniak
Journal:  Int J Oncol       Date:  2009-03       Impact factor: 5.650

7.  Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance.

Authors:  Mei Cao; Shang-Mian Yie; Sheng-Min Wu; Shu Chen; Be Lou; Xu He; Shang-Rong Ye; Ke Xie; Lin Rao; En Gao; Nai-Yao Ye
Journal:  Clin Exp Metastasis       Date:  2009-06-12       Impact factor: 5.150

8.  Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.

Authors:  Kyung Hee Lee; Eun Young Choi; Sung Ae Koh; Min Kyoung Kim; Kyeong Ok Kim; Si Hyung Lee; Byung Ik Jang; Se Won Kim; Sang Woon Kim; Sun Kyo Song; Joon Hyuk Choi; Jae-Ryong Kim
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

Review 9.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

10.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].

Authors:  Katayoon H Emami; Cu Nguyen; Hong Ma; Dae Hoon Kim; Kwang Won Jeong; Masakatsu Eguchi; Randall T Moon; Jia-Ling Teo; Se Woong Oh; Hak Yeop Kim; Sung Hwan Moon; Jong Ryul Ha; Michael Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.